HIV/AIDS

FDA Approves Once-Daily Idvynso Tablet for Treating HIV

Infectious Disease

FDA Approves Once-Daily Idvynso Tablet for Treating HIV

Apr 30, 2026

2 min read

Introduction of HAART Partially Responsible for Resurgence in Syphilis

Introduction of HAART Partially Responsible for Resurgence in Syphilis

Apr 30, 2026

1 min read

Very Few Patients With HIV Report Using Long-Acting Injectable ART

Infectious Disease

Very Few Patients With HIV Report Using Long-Acting Injectable ART

Apr 29, 2026

1 min read

AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions

AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions

HealthDay Staff

Apr 20, 2026

2 min read

CDC: Proportion of Extensively Drug-Resistant Shigella Isolates Increasing

Infectious Disease

CDC: Proportion of Extensively Drug-Resistant Shigella Isolates Increasing

Apr 14, 2026

1 min read

Title X Funding Restored, but New Rules Raise Concerns

Title X Funding Restored, but New Rules Raise Concerns

HealthDay Staff

Apr 10, 2026

2 min read

Switching From HIV Protease Inhibitors to Integrase Strand Transfer Inhibitors Tied to Diabetes Risk

Switching From HIV Protease Inhibitors to Integrase Strand Transfer Inhibitors Tied to Diabetes Risk

Apr 07, 2026

2 min read

Single-Tablet Bictegravir-Lenacapavir Noninferior to Complex Regimens for HIV-1

Infectious Disease

Single-Tablet Bictegravir-Lenacapavir Noninferior to Complex Regimens for HIV-1

Mar 09, 2026

1 min read

Nearly 20 States Scale Back HIV Medication Programs

Nearly 20 States Scale Back HIV Medication Programs

HealthDay Staff

Mar 03, 2026

3 min read

Read More

www.healthday.com